At a glittering award ceremony held on the 13th of June 2017 at Manchester’s Midland Hotel, in the heart of the city, Nanomerics’ was awarded first prize in the Royal Society of Chemistry's Emerging Technologies Competition (Health). The award recognises the commercial and scientific excellence associated with Nanomerics and its MET platform, the technology underpinning Nanomerics’ business.
From a wide field of international companies with applicants offering various technologies, all grounded in the chemical sciences, a selection of ten companies had been shortlisted to pitch earlier in the day. Nanomerics competed in the health category and was first up onto the pitching stage, showcasing Nanomerics’ MET to the judges and wider audience. The technologies were judged by a trio of seasoned judges with over 60 years of pharmaceutical industry experience between them: Kurt Pike from Astrazeneca, Ger Brophy from GE Healthcare and Simon Turner from Alacrita.
Nanomerics’ Chief Executive Officer (CEO), Professor Andreas Schatzlein and Chief Scientific Officer (CSO) Professor Ijeoma F. Uchegbu were on hand to accept the award on behalf of the company from the RSC's Chief Executive Robert Parker and BBC's TV Host Maggie Philbin, OBE. Says Nanomerics’ CEO, Professor Andreas G. Schatzlein “we are incredibly humbled to have been recognised by our peers and to be recognised at the Royal Society of Chemistry’s flagship event for companies working in the chemical sciences.” Nanomerics CSO says, “this award is a treasure of no equivalence for Nanomerics as it vindicates the work we have put into designing, optimising and utilising Nanomerics’ MET for eventual patient benefit.” The award included a commemorative plaque, a cash prize of £10,000, as well as a suite of training opportunities in media relations and other business skills for Nanomerics’ staff.